Skip to main content

Table 1 Clinical characteristics of hospital admissions for heart transplantation among patients with and without type 2 diabetes mellitus (T2D) in Spain, 2002–2021

From: Temporal trends and outcomes of heart transplantation in Spain (2002–2021): propensity score matching analysis to compare patients with and without type 2 diabetes

Year

2002–2005

2006–2009

2010–2013

2014–2017

2018–2021

P trend

T2D

 

N (%)*

171(19.19)

181(19.87)

154(17.43)

156(20.95)

186(19.15)

0.388

Women, n (%)

25(14.62)

28(15.47)

20(12.99)

21(13.46)

29(15.59)

0.947

Age, mean (SD)

57.68(6.13)

59.83(7.91)

58.34(6.8)

59.58(6.89)

59.27(7.17)

0.025

35–49 years, n (%)

15(8.77)

19(10.5)

18(11.69)

16(10.26)

19(10.22)

0.166

50–59 years, n (%)

82(47.95)

63(34.81)

65(42.21)

53(33.97)

65(34.95)

≥ 60 years, n (%)

74(43.27)

99(54.7)

71(46.1)

87(55.77)

102(54.84)

CCI, mean (SD)

1.49(0.81)

1.58(0.93)

1.64(0.87)

2.06(1.24)

2.28(0.92)

< 0.001

CCI = 0, n (%)

13(7.6)

16(8.84)

10(6.49)

10(6.41)

3(1.61)

< 0.001

CCI = 1, n (%)

83(48.54)

79(43.65)

61(39.61)

46(29.49)

30(16.13)

CCI ≥ 2, n (%)

75(43.86)

86(47.51)

83(53.9)

100(64.1)

153(82.26)

Obesity, n(%)

13(7.6)

6(3.31)

13(8.44)

9(5.77)

23(12.37)

0.020

Pulmonary hypertension, n(%)

24(14.04)

16(8.84)

33(21.43)

20(12.82)

30(16.13)

0.022

Valvular heart disease, n(%)

19(11.11)

22(12.15)

23(14.94)

28(17.95)

38(20.43)

0.081

Dilated cardiomyopathy, n(%)

104(60.82)

94(51.93)

96(62.34)

94(60.26)

123(66.13)

0.084

Ischemic heart disease, n(%)

101(59.06)

120(66.3)

79(51.3)

82(52.56)

97(52.15)

0.020

Congenital heart disease, n(%)

0(0)

0(0)

3(1.95)

4(2.56)

3(1.61)

0.097

NO DIABETES

N

757

762

621

739

702

 

Women, n (%)

126(16.64)

181(23.75)

159(25.6)

185(25.03)

189(26.92)

< 0.001

Age, mean (SD)

53.97(8.52)

55.64(9.22)

55.29(8.82)

54.97(9.26)

55.32(8.89)

0.004

35–49 years, n (%)

215(28.4)

187(24.54)

157(25.28)

206(27.88)

190(27.07)

0.008

50–59 years, n (%)

327(43.2)

295(38.71)

232(37.36)

274(37.08)

254(36.18)

≥ 60 years, n (%)

215(28.4)

280(36.75)

232(37.36)

259(35.05)

258(36.75)

CCI, mean (SD)

1.45(0.8)

1.49(0.83)

1.54(0.83)

1.77(0.94)

2.02(0.95)

< 0.001

CCI = 0, n (%)

59(7.79)

63(8.27)

37(5.96)

37(5.01)

22(3.13)

< 0.001

CCI = 1, n (%)

379(50.07)

353(46.33)

298(47.99)

274(37.08)

185(26.35)

CCI ≥ 2, n (%)

319(42.14)

346(45.41)

286(46.05)

428(57.92)

495(70.51)

Obesity, n(%)

19(2.51)

23(3.02)

20(3.22)

29(3.92)

39(5.56)

0.022

Pulmonary hypertension, n(%)

107(14.13)

110(14.44)

97(15.62)

96(12.99)

80(11.4)

0.208

Valvular heart disease, n(%)

125(16.51)

115(15.09)

107(17.23)

183(24.76)

166(23.65)

< 0.001

Dilated cardiomyopathy, n(%)

499(65.92)

486(63.78)

392(63.12)

462(62.52)

443(63.11)

0.689

Ischemic heart disease, n(%)

360(47.56)

351(46.06)

250(40.26)

301(40.73)

256(36.47)

< 0.001

Congenital heart disease, n(%)

12(1.59)

17(2.23)

18(2.9)

33(4.47)

43(6.13)

< 0.001

  1.  N number of admissions with heart transplantation, * Prevalence of T2D among patients who underwent a heart transplantation. CCI Charlson comorbidity index. The Charlson comorbidity index applies to different disease categories, the scores of which are added to obtain an overall score for each patient. We divided patients into three categories: low CCI (patients with no previously recorded disease), medium CCI (patients with one category), and high CCI (patients with two or more disease categories). To calculate the CCI, we used all disease categories, excluding diabetes and heart diseases. According to Bonferroni adjustment p values can be considered significant if < 0.0018 (0.05/28)